Pharmaceuticals | JNJ Innovation

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we envision a world without disease. To achieve this, we strive to couple our strong internal capabilities with the most compelling external science to transform how diseases are thought of being treated, cured, prevented and intercepted in the future.

Focus Areas

Our Pharmaceuticals business is divided into six core areas, Cardiovascular & Metabolism; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension. We seek innovation across all of these areas where there is significant unmet patient need.

CLICK a circle below to see the diseases we are targeting.

Metabolism, Retinal Diseases, Thrombosis

Cardiovascular and Metabolism

Cardiovascular and Metabolism
Gastroenterology, Rheumatology - IL-23 Pathway

Immunology

Immunology
Hepatitis, Respiratory Infections, Bacterial & Viral Vaccines

Infectious
Diseases and Vaccines

Infectious Diseases and Vaccines
Mood Disorders, Neurodegenerative Disorders, Schizophrenia, Glutamatergic Pathway Diseases

Neuroscience

Neuroscience
Prostate Cancer, Solid Tumor Targeted Therapy, Immuno-Oncology, Hematologic Malignancies

Oncology

Oncology
Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Pulmonary Hypertension

Pulmonary Hypertension

Collaboration Partners

Johnson & Johnson Innovation is comprised of a family of complementary teams that bring meaningful solutions and flexible approaches to support collaboration. From incubation facilities to early-stage investing – from venture funding to acquisition, our teams offer partners a full range of capabilities.

Text left

JLABS
If you are seeking incubation space for your early-stage company, or seeking to expand your start-up through an exchange of ideas and collaboration, make the connection with our incubation teams.